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Abstract
Purpose Among the many questionnaires available to
evaluate low back pain (LBP) patients, the Core Outcome
Measures Index (COMI) has the unique advantage to
investigate five dimensions using seven short questions.
The aim of this study was to explore additional properties
of the questionnaire in a French-speaking non-surgical
population.
Methods This study was conducted on 168 patients suf-
fering from subacute or chronic LBP and followed up for
6 months in three French-speaking countries. In addition to
basic psychometric properties (e.g., construct validity, floor
and ceiling effect, reproducibility), internal validity was
analyzed by a factor analysis using Cronbach’s alpha.
Responsiveness and sensitivity to change were assessed
through minimal detectable change (MDC), effect size, and
Minimal Clinically Important Improvement (MCII). We
used an anchor-based method with receiver operating
characteristic (ROC) curve analysis to assess MCII and the
Patient Acceptable Symptom State.
Results Construct validity, reliability (Cronbach’s
alpha = 0.87), reproducibility and the absence of floor and
ceiling effects were confirmed. Factor analysis indicated a
one-dimensional construct that validates the use of a sum
score. The MDC (2.1) was inferior to the MCII (2.3). The
limit below which the patient claims to be in a fair con-
dition (Patient Acceptable Symptom State) was set at 3.
Conclusions The COMI is a self-report questionnaire
with the capacity to easily and quickly explore several
dimensions in patients with LBP that can be then sum-
marized in a meaningful sum score. Additional knowledge
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provided by our study should encourage the widespread use
of the COMI among the spine community.
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Introduction
There are many questionnaires available to assess patients
with low back pain (LBP) [1]. Dimensions that are com-
monly considered important to assess include pain, symp-
tom-specific function, generic well-being, social and work
disability, and satisfaction with treatment [2], but using a
specific questionnaire for each dimension leads to lengthy
assessment that is difficult to achieve in practice. The Core
Outcome Measures Index (COMI) was proposed originally
to shorten the evaluation time when assessing pain, func-
tion, symptom-specific well-being, quality of life, and
disability. This 7-item, short and easy to use questionnaire
[2] appears to be a reliable and valid [3–5] instrument to
assess these five dimensions in LBP patients and it is now
routinely used by spine surgeons in the Spine Tango reg-
istry (European Spine registry) [6]. The French version of
the COMI has been recently validated in patients mainly
located in the French-speaking region of Switzerland [4].
However, important psychometric properties (e.g., sensi-
tivity to change) could not be studied in the absence of
follow-up after treatment.
The primary aim of this study was to acquire a deeper
general knowledge of the measurement characteristics of
this questionnaire, e.g., by defining the Patient Acceptable
Symptom State (PASS) [7] with a special emphasis on non-
surgical patients. In contrast with our previous study and in
order to increase the generalizibility of the results, this
study was performed in three different French-speaking
populations.
Materials and methods
Study design/setting
A prospective 6-month multicenter cohort study was con-
ducted in France, the French-speaking region of Belgium,
and the French-speaking region of Switzerland. Patients
were recruited from non-surgical spine centers. Inclusion
criteria were LBP with or without leg pain for at least
4 weeks, a pain intensity score of at least 3 on a visual
analog pain scale ranging from 0 to 10, and fluency in the
French language. Exclusion criteria were a diagnosis of
specific LBP (tumor, infection, spondyloarthropathy, or
trauma) or the presence of co-morbidities severe enough to
interfere with the evaluation of function (e.g., decompen-
sated heart failure, symptomatic knee osteoarthritis). After
written informed consent was obtained, patients were asked
to complete a questionnaire booklet. To investigate the
reproducibility, patients received a shorter booklet with the
instruction to complete it a week later at home and then to
returned it by mail (short-term follow-up). A full follow-up
evaluation was scheduled 4–6 months later. The choice of
treatment was left to the decision of each investigator. The
sample size was determined according to quality criteria
for health status questionnaires [8]. The study was
approved by the Institutional Ethics Committee of the
University of Geneva Hospitals, Geneva, Switzerland.
Patient-based outcome measures
The domains included in the COMI are pain symptoms
(two items related to back and leg pain, respectively),
function, symptom-specific well-being, generic quality of
life (QoL) (all in the past week), and work and social
disability in the previous month. Pain scores are indicated
on a 0–10 numeric rating scale. Response categories for
other items are 5-point adjectival or Likert scales (The
French version is available online as a supplementary file;
for English version see [9]). The two disability items asked
patients to record the number of days that back pain
affected their work and daily activities during the previous
4 weeks. These two variables were recorded into categor-
ical variables of five points (0, 1–7, 8–14, 15–21,
C22 days). The pain score is recorded as the higher of the
two pain scale scores (back or leg). For the remaining
items, each incremental step is allocated 2.5 points and
range from 0 (‘‘excellent condition’’) to 10 (‘‘worst con-
dition’’). Scores for social and work disability are averaged
to form one disability score. The COMI sum score is
computed by the addition of the five subscales (pain,
function, symptom-specific well-being, general QoL, and
disability) divided by five and thus ranges from 0 (‘‘best
health status’’) to 10 (‘‘worst health status’’) [5].
In the present study, the French version of the COMI
used was identical in the three countries. The validation
process of the English to French translation has been pre-
viously reported and basic psychometric properties of this
version (construct validity and reproducibility) were shown
to be acceptable in a small cohort of LBP patients recruited
from orthopedic and non-surgical spine centers [4].
At baseline, the questionnaire booklets included ques-
tions about sociodemographic variables (age, gender,
family status, education, work status), pain characteristics
(time since the first episode of LBP, duration of the present
episode, previous back surgery, intensity of back-related
pain during the past week ranked on a 5-item Likert scale
[‘‘no pain’’ to ‘‘extreme pain’’]), back pain-related
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disability [French version [10] of the Roland and Morris
disability questionnaire (RMDQ)], daily life activity, work
and leisure, anxiety and depression, social interest [French
version [11] of the Dallas Pain Questionnaire (DPQ),
which enables to calculate a subscore for each four sub-
scales as well as the sum score], and health-related QoL
[French version [12] of the Euroquol 5 Dimensions Ques-
tionnaire (EQ-5D)]. In addition to the COMI, the clinical
evolution was evaluated at short-term follow-up by a
transition question on a 7-point Likert scale (from ‘‘strong
improvement’’ to ‘‘strong worsening’’).
At 6-month follow-up, patients were asked to complete
the same questionnaire booklet as at baseline; treatments
administered since study inclusion were also recorded.
Treatment efficacy was assessed on a 5-point Likert scale
(from ‘‘no effect’’ to ‘‘excellent effect, almost no symptoms
at all’’) and patient global perceived effect by the same
7-point Likert scale as used at short-term follow-up (from
‘‘strong improvement’’ to ‘‘strong deterioration’’) [13].
Patients were asked also whether they considered their
present state as satisfactory through the following question:
‘‘Taking into account all what you have to do in your daily
life, your pain, and your disability, is your present state
satisfactory?’’ (yes/no answer) [14].
Statistical analysis
According to recommendations [8], a minimum study
sample size of 150 patients was required to ensure suffi-
cient power. Missing data were treated according to the
specific recommendations for each questionnaire. COMI
scores were computed only when all data were present.
Floor and ceiling effects were determined for the COMI
total score and for each of the five subscales by computing
the percentage of answers at both extremities of the total
score and each subscale.
The construct validity of the COMI was explored by
investigating the correlations between the COMI subscales
and their corresponding validated full-length questionnaire
(e.g., RMDQ for the function subscale) using Spearman
rank correlation coefficients, corrected for ties. Spearman’s
Rho coefficients were interpreted as follows: Rho
0.81–1.0=‘‘excellent’’; 0.61–0.80=‘‘very good’’;
0.41–0.60= ‘‘good’’; 0.21–0.40 = ‘‘fair’’; and
0–0.20 = ‘‘poor’’ [15, 16]. Pre-specified hypotheses were
made and good correlations were expected at least between
the COMI pain and the 5-item Likert pain scale, the COMI
function and the RMDQ or daily life activity subscale of
DPQ, the COMI disability and the DPQ work and leisure
subscale, the COMI QoL and the EQ-5D, as well as
between the COMI sum score and DPQ total score. No
specific correlation was expected for the COMI well-being
as it has been reported in several studies that this specific
scale is not related to other commonly used questionnaires
[3–5]. The unidimensionality of the COMI score was first
assessed using principal component analysis (PCA). Reli-
ability of the scale was then determined using Cronbach’s
alpha.
Reproducibility was determined by comparing baseline
scores to those reported at short-term follow-up (scheduled
1 week later) among patients who reported no or only
minimal change from the time of inclusion. The weighted
kappa for single items and the intraclass coefficient of
correlation (ICC) for the total score were used, as well as
the Bland–Altman plotting method which indicates the
smallest detectable difference (SDD; i.e., the amount of
detectable change above the random measurement error).
The 95 % limits of agreements were calculated by the
Bland and Altman method [17] i.e., the mean of the dif-
ference between the two measures ±1.96 9 the standard
deviation (SD) of this difference.
Assessment of the minimal detectable change (MDC)
was done by multiplying 1.96 to the difference in score
between baseline and short-term follow-up among patients
declaring no or minimal improvement [15, 18]. The minimal
clinically important improvement (MCII) was determined
using an anchor method based on the patient’s assessment in
response to the treatment at 6 months by a 5-point Likert
scale (0 = ‘‘no effect’’, 1 = ‘‘slight effect’’, 2 = ‘‘moderate
effect, could be better, 3 = good effect, still with some
symptoms, 4 = excellent effect’’) [19]. These results were
then divided into patients for whom the treatment did not
result in any change (0 and 1) and those for whom the
treatment provided change (2–4). The threshold was deter-
mined by subtracting the mean change score of the group of
patients who observed a treatment effect from that of the
group who did not report any treatment effect. The rela-
tionship between the change in COMI sum score and MCII
was assessed also by receiver operating characteristic (ROC)
curve analysis and the determination of the area under the
curve (AUC). The standardized variation of the items and
the total score was assessed by effect sizes (mean difference
divided by the SD).
PASS was determined using an anchor method based on
the patient’s answer to the statement: ‘‘Taking into account
all activities you have to perform in your daily life, your
amount of pain, and the level of physical disability, if you
were to remain the same for the next months, would this be
acceptable for you?’’ [20]. The threshold for PASS was
determined as being the 75th percentile of the COMI sum
score at 6-month follow-up of patients answering ‘‘yes’’ to
this statement [20]. The relationship between the change in
COMI sum score and PASS was also assessed by ROC and
AUC curve analyses.
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Results
Eleven centers recruited 168 patients from May 2009 to
June 2010. There were at least two centers in each country
(France, Belgium, and Switzerland) recruiting more than
15 patients. The short-term questionnaire (for the repro-
ducibility study) was completed by 138 of 168 patients
(mean number of days between baseline and short-term
questionnaire, 12.8; SD, 32.0). Long-term follow-up was
completed by 142 patients (mean number of months
between baseline and long-term follow-up, 5.5; SD 1.5).
Patient baseline characteristics
Patients (n = 168) had a mean (SD) age of 45.5 (12.2)
years; 56.1 % were female. The current episode of back
pain of most patients (82 %) had lasted for more than
3 months (Table 1). Fifteen percent had symptoms and
signs compatible with lumbar radiculopathy. Twenty-five
patients had undergone previous back surgery (a discec-
tomy for half of them). Pain, function, and QoL-related
characteristics of patients at baseline and after treatment at
6-month follow-up are given in Table 2.
Acceptability and floor and ceiling effect
The number of missing items ranges from 2.4 to 3.6 %
with 4.8 % of questionnaires having at least one missing
item (Table 3). Although several items presented with
some significant floor or ceiling effect, no such effect was
observed for the COMI sum score (Table 3).
Internal validity
The first PCA of the five items explains 64.3 % of vari-
ance. While the eigen value for the second factor was
Table 1 Baseline
characteristics of patients
(n = 168)
LBP low back pain
a According to the Paris Task
Force classification [26]
Characteristics Categories N (%)
Gender, female (n = 168) 96 (56.1)
Type of LBPa (n = 158) LBP without radiating pain 76 (48.1)
Non-specific radiation below gluteal fold 31 (19.6)
Non-specific radiation below the knee 27 (17.1)
Radicular pain 24 (15.2)
Duration of pain (n = 164) 4–7 weeks 18 (11.0)
7 weeks–3 months 11 (6.7)
3–6 months 30 (18.3)
6–18 months 32 (19.5)
[18 months 73 (44.5)
Previous episode of LBP (n = 168) 138 (85.2)
Level of education (n = 160) Obligatory schooling (9 years of education) 36 (22.5)
Professional diploma 58 (36.3)
University 66 (41.3)
Type of usual work (n = 159) Sedentary 48 (30.2)
Physical 61 (38.4)
A mix of both 50 (31.4)
Work status (n = 163) Employed 90 (55.2)
Unemployed 11 (6.7)
Insurance beneficiary (disease, accident, invalidity) 42 (25.8)
Retired 10 (6.1)
No paid activity 5 (3.1)
Other 5 (3.1)
Duration of sick leave None 51 (32.9)
(n = 155) \7 weeks 24 (15.5)
7 weeks–3 months 10 (6.5)
3–6 months 19 (12.3)
6–18 months 19 (12.3)
[18 months 16 (10.3)
Not applicable 16 (10.3)
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slightly above 1, the screen plot clearly favored a one-
factor solution. Reliability measured by Cronbach’s alpha
was 0.87.
Construct validity
All hypotheses were fulfilled for construct validity. The
COMI sum score and all subscales of the COMI, except
COMI well-being, had a good or very good correlation
with their respective reference questionnaire ranging from
0.52 (between COMI function and RMDQ) to 0.65
(between COMI sum score and DPQ sum score). As
expected, COMI well-being showed a low correlation with
all reference questionnaires, the highest correlation being
with EQ-5D (0.39).
Reproducibility
Of the 138 patients who responded to the short-term fol-
low-up questionnaire, 132 reported no or only minimal
change from inclusion and were thus included in the test–
retest analysis. Test–retest agreement was high for all items
(range 0.66–0.88) except for the item on well-being
(weighted kappa, 0.48). The test–retest agreement for the
total score was very high at 0.81 (95 % CI, 0.74–0.86). The
Bland–Altman plotting method indicating the SDD was
2.09 (Fig. 1).
Responsiveness, sensitivity to change, and additional
characteristics
The MDC for single items was less than 2.5 points on
the 10-point scale, except for the questions on pain
(MDC for COMI back pain = 2.9; COMI leg
pain = 3.7; COMI pain = 2.7). The MDC for the COMI
sum score in this population was 2.1. However, the mean
difference between scores among stable patients was
very low. By contrast, the MCII for the sum score was
2.3. The AUC for the prediction of patient’s own
assessment in response to treatment by the change in
COMI sum score was 0.80, meaning that a patient
reporting no or a slight effect had a 80 % chance of
having a lower COMI sum score change than a patient
who reported at least a moderate treatment effect. The
effect size of the COMI sum score was 1.01.
The PASS for the sum score (scale from 0 to 10) was
3.05. This threshold on the COMI sum score at follow-up
correctly classified 90.6 % of the patients who declared to
be dissatisfied with their present state and 74.3 % of
patients reporting as satisfied. The AUC for the prediction
of PASS by the COMI sum score at follow-up was 0.84
(Fig. 2), meaning that a patient who is dissatisfied with his/
Table 3 Item characteristics of
the Core Outcome Measures
Index (COMI) at baseline
(n = 168 patients)
SD standard deviation, PCA
principal component analysis
a Each scale rated from 0 to 10
Missing
(%)
% at lowest
value
% at highest
value
Lowest
value
Highest
value
Meana
(SD)
Loading
of PCA
COMI back pain 3.0 0.6 0.6 0 10 5.5 (2.0) –
COMI leg pain 3.6 21.4 0.6 0 10 3.6 (2.9) –
COMI pain 2.4 0.0 1.2 2 10 6.0 (1.9) 0.70
COMI social
disability
3.0 13.7 32.1 0 10 5.6 (3.7) –
COMI work disability 3.0 33.9 31.0 0 10 4.5 (4.3) –
COMI disability 3.0 13.1 25.0 0 10 5.1 (3.7) 0.60
COMI function 2.4 0.6 9.5 0 10 6.0 (2.1) 0.87
COMI well-being 2.4 0.0 49.4 2.5 10 8.4 (1.9) 0.59
COMI quality of life 2.4 1.2 7.7 0 10 5.8 (2.1) 0.78
COMI sum score 4.8 0.0 0.6 2.4 10 6.3 (1.8) –
Table 2 Pain, function, and quality of life-related characteristics of
patients at baseline and after treatment at 6-month follow-up (mean
[SD])
Baseline
(n = 168)
Follow-up
(n = 142)
Back pain (0–10) 5.5 (2.0) 3.7 (2.6)
Leg pain (0–10) 3.6 (2.9) 2.6 (2.8)
Roland and Morris disability
questionnaire (0–24)
12.9 (5.0) 7.5 (6.5)
Dallas pain questionnaire
Daily activities (0–100) 60.5 (17.6) 40.6 (25.9)
Work and leisure (0–100) 57.8 (23.5) 37.2 (29.8)
Anxiety and depression (0–100) 42.5 (26.4) 29.4 (28.6)
Social interest (0–100) 34.1 (24.2) 24.5 (24.7)
Euroquol 5 dimensions questionnaire
(0–1)
0.4 (0.2) 0.6 (0.3)
COMI sum score 6.3 (1.8) 4.0 (2.6)
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her present back condition has an 84 % chance of having a
higher COMI sum score at follow-up than a patient who is
satisfied.
Discussion
The basic psychometric properties (internal consistency,
reproducibility, floor and ceiling effect) of the French
adaptation of the COMI were confirmed in a prospective
cohort of non-surgical patients. The recruitment performed
in three different French-speaking countries is an important
point for the generalizability of the questionnaire. More
importantly, it provides additional clinically meaningful
psychometric properties that have not been previously
reported in any other language [3–5]. It is the first time that
a factor analysis is reported for the COMI. Although it is in
essence a multidimensional tool, this analysis surprisingly
indicates that the COMI has a one-dimensional construct.
We hypothesize that this may refer to the fact that this
questionnaire captures something unique for all these
patients (i.e., they are all suffering from LBP) and might
indicate that the investigated dimensions have been ade-
quately chosen to provide a comprehensive evaluation of
these patients. Importantly, this finding validates the use of
a sum score that effectively represents the patient’s global
state. Interestingly, this has been already reported for a
version of the COMI specifically developed for neck pain
patients [21].
PASS is an emerging concept that has recently been
reported for other self-report questionnaires in the field of
musculoskeletal diseases [22, 23], but was not previously
determined for the COMI. Patients with a COMI sum score
equal or inferior to 3 can be confidently considered as
having reached an acceptable symptom state
(AUC = 0.84). Complementary to MCII, which charac-
terizes an improvement from a previous state, PASS is
characteristic of a present state of being. PASS appears to
be less influenced by baseline characteristics than MCII
[23] and to be stable over time [24]. PASS scores are
increasingly used to report results in clinical trials [25] and
are proposed as a tool to help guide clinical and surgical
decisions [26].
In our patient cohort, the value from which an
improvement can be considered to have clinical relevance
(MCII) is 2.3. The fact that the MCII is above the MDC
Fig. 2 Relationship between the change in the Core Outcome
Measures Index (COMI) sum score and the Patient Acceptable
Symptom State (PASS) assessed using ROC curve analysis. The area
under the curve for the prediction of PASS by the COMI sum score at
follow-up was 0.84, meaning that a patient who is dissatisfied has a
84 % chance of having a higher COMI sum score at follow-up than a
patient who is satisfied
Fig. 1 Bland–Altman plotting
showing limits of agreement
between the Core Outcome
Measures Index (COMI) mean
score at baseline and at short
term (average time 12 days)
among stable patients
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(2.1) confirms that MCII can be adequately used in clinical
research and practice. The AUC (0.80) for the change in
the COMI sum score is high and shows a good ability to
predict the patient’s assessment in response to the treat-
ment at 6 months. The value of MCII in this study is
similar to the value found (2.6) in a large cohort of surgical
patients [27]. The effect size of the COMI sum score (1.01)
is large and similar to that obtained in other studies [3, 5],
thus indicating that this questionnaire has also a good
responsiveness (sensitivity to change) in non-surgical
patients.
Some of the new psychometric properties of the COMI
described in this study, like the PASS score, should be
replicated in other populations (e.g., surgical patients)
before being generalized. Other important results like
factor analysis should not be influenced by translation or
clinical characteristics of the patients and are thus be valid
for all translations. Lastly, for parameters like ICC MDC
and MCII, our results confirm those reported in other cross-
cultural adaptations and thus can be considered reliable [3,
5, 9, 28, 29].
In conclusion, the French cultural adaptation of this self-
report questionnaire has adequate psychometric properties
to study and follow-up subacute and chronic LBP patients
in large cohort studies as presently done in Spine Tango
[6]. Furthermore, considering its intrinsic qualities, namely
brevity, multidimensionality, ease of application and
scoring, the COMI has all the necessary criteria to be used
in daily practice care by spine specialists or even general
practitioners. The COMI is a useful instrument providing a
comprehensive evaluation that helps to document treatment
efficacy in a patient population notoriously difficult to
treat.
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